About Orchid Pharma
Orchid Pharma is a company based in Chennai (India) founded in 1992 by Kailasam Raghavendra Rao was acquired by Dhanuka Laboratories in July 2019. The company has 1,050 employees as of March 31, 2024. Orchid Pharma offers products and services including Pharmaceutical Drugs and Research Services.
- Headquarter Chennai, India
- Employees 1050 as on 31 Mar, 2024
- Founders Kailasam Raghavendra Rao
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Orchid Pharma Limited
-
Annual Revenue
$107.57 M (USD)12.24as on Mar 31, 2025
-
Net Profit
$11.66 M (USD)8.13as on Mar 31, 2025
-
EBITDA
$13.58 M (USD)4.25as on Mar 31, 2025
-
Latest Funding Round
$48.78 M (USD), Post-IPO
Jun 28, 2023
-
Investors
Société Générale
& 5 more
-
Employee Count
1050
as on Mar 31, 2024
-
Acquired by
Dhanuka Laboratories
(Jul 05, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Orchid Pharma
Orchid Pharma is a publicly listed company on the NSE with ticker symbol ORCHPHARMA in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Orchid Pharma
Orchid Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Drugs and Research Services.
Research, manufacturing, and marketing of drugs for various therapeutic uses are conducted by the company.
Development of new pharmaceutical avenues is undertaken across multi-therapeutic domains.
People of Orchid Pharma
Unlock access to complete
Unlock access to complete
Funding Insights of Orchid Pharma
Investors in Orchid Pharma
Orchid Pharma has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Société Générale, MIT and Dhanuka Laboratories.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are invested in by 238 Plan Associates.
|
Locked | Locked | Locked | |
|
MIT is recognized as a leading institution for education and research.
|
Locked | Locked | Locked | |
|
Full-service corporate advisory is provided to global clients.
|
Locked | Locked | Locked |
Investor details for Orchid Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orchid Pharma
Investment portfolio details for Orchid Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Orchid Pharma
Detailed financials for Orchid Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orchid Pharma Comparisons
Peer comparison for Orchid Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Orchid Pharma
Detailed competitors of Orchid Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orchid Pharma
Complete news archive for Orchid Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orchid Pharma
Orchid Pharma was founded in 1992 and raised its 1st funding round 31 years after it was founded.
Orchid Pharma is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
As of Mar 31, 2024, the latest employee count at Orchid Pharma is 1,050.
Annual revenue of Orchid Pharma is $107.57M as on Mar 31, 2025.
Orchid Pharma was established in 1992 in Chennai, India, within the pharmaceutical sector. APIs, finished dosage forms, nutraceuticals, and related products are developed and manufactured. Operations encompass NCE discovery, novel drug delivery systems, and CRAMS services. USFDA- and UK MHRA-approved facilities are maintained in Chennai and Aurangabad for production activities.
Orchid Pharma offers Pharmaceutical Drugs and Research Services.
Yes, Orchid Pharma is publicly traded on NSE under the ticker symbol ORCHPHARMA.
Orchid Pharma has 6 investors. Key investors include Société Générale, MIT, Dhanuka Laboratories, quant Mutual, and Carnelian.
The ticker symbol of Orchid Pharma is ORCHPHARMA on NSE.